AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Larijani, GE Donati, F Bikhazi, G Bartkowski, R Kenaan, CA Plaud, B Goldberg, ME
Citation: Ge. Larijani et al., A multicenter evaluation of the time-course of action of two doses of rapacuronium after early and late reversal with neostigmine, ANESTH ANAL, 93(2), 2001, pp. 370-374

Authors: Weisman, KM Larijani, GE Goldstein, MR Goldberg, ME
Citation: Km. Weisman et al., Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men, PHARMACOTHE, 20(4), 2000, pp. 383-386

Authors: Weisman, KM Larijani, GE Goldberg, ME
Citation: Km. Weisman et al., Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy, UROLOGY, 56(3), 2000, pp. 544-544

Authors: Larijani, GE Cypel, D Gratz, I Mroz, L Mandel, R Afshar, M Goldberg, ME
Citation: Ge. Larijani et al., The efficacy and safety of EMLA (R) Cream for awake fiberoptic endotracheal intubation, ANESTH ANAL, 91(4), 2000, pp. 1024-1026

Authors: Larijani, GE
Citation: Ge. Larijani, Evaluating neuromuscular blocking agents - Introduction, AM J HEAL S, 56(11), 1999, pp. S3-S4

Authors: Larijani, GE Zafeiridis, A Goldberg, ME
Citation: Ge. Larijani et al., Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent, PHARMACOTHE, 19(10), 1999, pp. 1118-1122

Authors: Goldberg, ME Larijani, GE Eger, EI
Citation: Me. Goldberg et al., Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MACsevoflurane for 8 hours, PHARMACOTHE, 19(10), 1999, pp. 1173-1176
Risultati: 1-7 |